Cardiometabolic Risk Reduction Through Selective Amylin Receptor Agonism: Emerging Cardiovascular Implications of Eloralintide

More on Inflammation

• Six blood metabolites distinguish metabolic health in obesity

  Frontiers in Endocrinology · 4 Oct 2026

• Risk factors for atherosclerosis diverge across vascular beds

  American Journal of Preventive Cardiology · 4 Oct 2026

  

• Orforglipron matches insulin glargine on cardiovascular safety

  Lancet · 4 Oct 2026

• Survodutide reduces weight in adults with diabetes and obesity

  The New England Journal of Medicine · 4 Oct 2026